FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP
January 16th 2024Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.
Read More
Smaller Doses of Monkeypox Vaccine Elicits Equal Immune Response in People Living With, Without HIV
January 3rd 2024The study results also determined that those who were previously vaccinated against smallpox had a 2.7 times higher immune response than those who were not previously vaccinated.
Read More
Expert: The Evolution of HIV Care, Treatment Options, How Pharmacists Can Assist in Providing Care
December 18th 2023Using information from clinical studies and her experiences working in the field, Stephanie Kirk describes treatment options that are on the horizon, and how removing stigma is key in HIV care.
Read More
PrEPVacc HIV Vaccine Trial Halted Due to Potential Inefficacy, But Oral PrEP Regimens Continue
December 18th 2023The study, which consists of 3 trials, will continue with oral PrEP regimens; however, the vaccination trials have stopped due to the unlikely chance of the vaccine showing efficacy.
Read More